These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 19419831)
1. C-peptide and chronic complications in patients with type-2 diabetes and the metabolic syndrome. Mavrakanas T; Frachebois C; Soualah A; Aloui F; Julier I; Bastide D Presse Med; 2009 Oct; 38(10):1399-403. PubMed ID: 19419831 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical profile of metabolic syndrome among type 1 diabetes mellitus patients in southern India. Billow A; Anjana RM; Ngai M; Amutha A; Pradeepa R; Jebarani S; Unnikrishnan R; Michael E; Mohan V J Diabetes Complications; 2015 Jul; 29(5):659-64. PubMed ID: 25899474 [TBL] [Abstract][Full Text] [Related]
3. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study. Savage S; Estacio RO; Jeffers B; Schrier RW Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587 [TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome. Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164 [TBL] [Abstract][Full Text] [Related]
5. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus. Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684 [TBL] [Abstract][Full Text] [Related]
6. The KID Study VI: diabetic complications and associated diseases in younger type 2 diabetics still performing a profession. Prevalence and correlation with duration of diabetic state, BMI and C-peptide. Haupt E; Benecke A; Haupt A; Herrmann R; Vogel H; Walter C Exp Clin Endocrinol Diabetes; 1999; 107(7):435-41. PubMed ID: 10595594 [TBL] [Abstract][Full Text] [Related]
7. Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes. Kang ES; Kim HJ; Ahn CW; Park CW; Cha BS; Lim SK; Kim KR; Lee HC Diabetes Res Clin Pract; 2005 Aug; 69(2):151-9. PubMed ID: 16005364 [TBL] [Abstract][Full Text] [Related]
8. Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabetic patients. Kim BY; Jung CH; Mok JO; Kang SK; Kim CH Acta Diabetol; 2012 Feb; 49(1):9-15. PubMed ID: 21212993 [TBL] [Abstract][Full Text] [Related]
9. [Type 2 diabetic patients in a population sample from Ribeirão Preto area (São Paulo)]. Foss MC; Paccola GM; de Souza NV; Iazigi N AMB Rev Assoc Med Bras; 1989; 35(5):179-83. PubMed ID: 2486414 [TBL] [Abstract][Full Text] [Related]
10. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus. Arikan E; Sabuncu T; Ozer EM; Hatemi H J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of overt diabetic nephropathy in patients with noninsulin-dependent diabetes mellitus. Norymberg C; Shenkman L Isr J Med Sci; 1991 Mar; 27(3):124-30. PubMed ID: 2016150 [TBL] [Abstract][Full Text] [Related]
12. [Status of the sympatho-adrenal system in patients with diabetes mellitus: dependence on the course of the disease and the presence of late complications]. Chandrashekar-Reddi KM; Balabolkin MI; Stoilov LD Probl Endokrinol (Mosk); 1994; 40(6):13-4. PubMed ID: 7740027 [TBL] [Abstract][Full Text] [Related]
13. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus. Gabat S; Keller C; Kempe HP; Amiral J; Ziegler R; Ritz E; Bergis KH; Wahl P; Nawroth P Vasa; 1996; 25(3):233-41. PubMed ID: 8795304 [TBL] [Abstract][Full Text] [Related]
14. Relation between the serum level of C-peptide and risk factors for coronary heart disease and diabetic microangiopathy in patients with type-2 diabetes mellitus. Inukai T; Matsutomo R; Tayama K; Aso Y; Takemura Y Exp Clin Endocrinol Diabetes; 1999; 107(1):40-5. PubMed ID: 10077354 [TBL] [Abstract][Full Text] [Related]
15. [Quality of blood sugar control and late complications of diabetes]. Sélam JL Rev Med Suisse Romande; 1995 Sep; 115(9):653-7. PubMed ID: 7481350 [No Abstract] [Full Text] [Related]
16. Circulating levels of Hsp27 in microvascular complications of diabetes: Prospects as a biomarker of diabetic nephropathy. Jakhotia S; Sivaprasad M; Shalini T; Reddy PY; Viswanath K; Jakhotia K; Sahay R; Sahay M; Reddy GB J Diabetes Complications; 2018 Feb; 32(2):221-225. PubMed ID: 29175119 [TBL] [Abstract][Full Text] [Related]
17. Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes. Suguro T; Watanabe T; Kodate S; Xu G; Hirano T; Adachi M; Miyazaki A Clin Sci (Lond); 2008 Dec; 115(11):327-34. PubMed ID: 18338983 [TBL] [Abstract][Full Text] [Related]
18. Relationship between serum C-peptide level and diabetic retinopathy according to estimated glomerular filtration rate in patients with type 2 diabetes. Chung JO; Cho DH; Chung DJ; Chung MY J Diabetes Complications; 2015 Apr; 29(3):350-5. PubMed ID: 25623633 [TBL] [Abstract][Full Text] [Related]
19. Associations between clinical characteristics and chronic complications in latent autoimmune diabetes in adults and type 2 diabetes. Lu J; Hou X; Zhang L; Hu C; Zhou J; Pang C; Pan X; Bao Y; Jia W Diabetes Metab Res Rev; 2015 May; 31(4):411-20. PubMed ID: 25448723 [TBL] [Abstract][Full Text] [Related]
20. Retinopathy, neuropathy and nephropathy in non-insulin-dependent diabetic patients. Tai TY; Tseng CH; Sung SM; Huang RF; Chen CZ; Tsai SH J Formos Med Assoc; 1991 Oct; 90(10):936-40. PubMed ID: 1685173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]